Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: An eight-year multicenter study

1. The vast majority of patients with psoriasis flared after stopping ustekinumab treatment. Treatment response, patient characteristics and use of immunosuppressants after cessation of ustekinumab were predictors of time to relapse while off ustekinumab.2. Given high rates of psoriasis relapse, withdrawal of ustekinumab cannot be recommended.

http://bit.ly/2S7vPtZ